Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kramer

Showing results (161-170 of 240) with videos related to

Pageof 24
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2013
Sex and body mass index but not CXCL12 801 G/A polymorphism determine the efficacy of hematopoietic cell mobilization: a study in healthy volunteer donorsJuliane Lenk, Martin Bornhauser, Michael Kramer, et al.
American Journal of Obstetrics and Gynecology|December 20, 2011
The preterm birth syndrome: a prototype phenotypic classificationJose Villar, Aris T Papageorghiou, Hannah E Knight, et al.
BMC Medicine|September 29, 2016
Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST)Elise Launay, Jérémie F Cohen, Patrick M Bossuyt, et al.
Blood Advances|January 10, 2022
Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatmentRaphael Teipel, Frank Kroschinsky, Michael Kramer, et al.
European Journal of Haematology|September 24, 2017
Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patientsSabine Kayser, Maximilian Feszler, Julia Krzykalla, et al.
Hepatology Communications|January 6, 2025
Serum amyloid P (PTX2) attenuates hepatic fibrosis in mice by inhibiting the activation of fibrocytes and HSCsMin Cong, Raquel Carvalho Gontijo Weber, Sadatsugu Sakane, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 16, 2025
Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DRMaximilian A Röhnert, Chiara Löffler, Michael Kramer, et al.
Leukemia & Lymphoma|November 8, 2011
Survey and analysis of the efficacy and prescription pattern of sorafenib in patients with acute myeloid leukemiaChristoph Röllig, Christian Brandts, Shabnam Shaid, et al.
Oncoimmunology|November 11, 2017
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor modelElham Pishali Bejestani, Marc Cartellieri, Ralf Bergmann, et al.
Leukemia|July 19, 2022
Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemiaMaximilian A Röhnert, Michael Kramer, Jonas Schadt, et al.
Pageof 24

Showing results (161-170 of 240) with videos related to

Sort By:
Pageof 24
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2013
Sex and body mass index but not CXCL12 801 G/A polymorphism determine the efficacy of hematopoietic cell mobilization: a study in healthy volunteer donorsJuliane Lenk, Martin Bornhauser, Michael Kramer, et al.
American Journal of Obstetrics and Gynecology|December 20, 2011
The preterm birth syndrome: a prototype phenotypic classificationJose Villar, Aris T Papageorghiou, Hannah E Knight, et al.
BMC Medicine|September 29, 2016
Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST)Elise Launay, Jérémie F Cohen, Patrick M Bossuyt, et al.
Blood Advances|January 10, 2022
Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatmentRaphael Teipel, Frank Kroschinsky, Michael Kramer, et al.
European Journal of Haematology|September 24, 2017
Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patientsSabine Kayser, Maximilian Feszler, Julia Krzykalla, et al.
Hepatology Communications|January 6, 2025
Serum amyloid P (PTX2) attenuates hepatic fibrosis in mice by inhibiting the activation of fibrocytes and HSCsMin Cong, Raquel Carvalho Gontijo Weber, Sadatsugu Sakane, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 16, 2025
Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DRMaximilian A Röhnert, Chiara Löffler, Michael Kramer, et al.
Leukemia & Lymphoma|November 8, 2011
Survey and analysis of the efficacy and prescription pattern of sorafenib in patients with acute myeloid leukemiaChristoph Röllig, Christian Brandts, Shabnam Shaid, et al.
Oncoimmunology|November 11, 2017
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor modelElham Pishali Bejestani, Marc Cartellieri, Ralf Bergmann, et al.
Leukemia|July 19, 2022
Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemiaMaximilian A Röhnert, Michael Kramer, Jonas Schadt, et al.
Pageof 24